We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
iShares Core MSCI Europe ETF
IEUR
$9.16B
| $2.85M | 0.01% |
50,760
-1,360
| -3% | -$79.3K |
|
|
B
652
Barrick Mining
B
$73.2B
| $2.84M | 0.01% |
157,619
+68,269
| +76% | +$1.37M |
|
653
Caesars Entertainment
CZR
$6.14B
| $2.82M | 0.01% |
25,142
-89
| -0.4% | -$8.69K |
|
654
NIO
NIO
$11.9B
| $2.81M | 0.01% |
78,951
+2,542
| +3% | +$104K |
|
655
RH
RH
$3.71B
| $2.79M | 0.01% |
4,187
+240
| +6% | +$165K |
|
656
Baxter International
BAX
$14.2B
| $2.79M | 0.01% |
34,688
-50,387
| -59% | -$3.98M |
|
|
UMPQ
657
DELISTED
Umpqua Holdings Corp
UMPQ
| $2.76M | 0.01% |
136,108
+15,066
| +12% | +$289K |
|
658
Banco Bradesco
BBD
$36.7B
| $2.75M | 0.01% |
790,235
+72,756
| +10% | +$290K |
|
659
CrowdStrike
CRWD
$218B
| $2.75M | 0.01% |
44,776
-6,436
| -13% | -$415K |
|
660
Marvell Technology
MRVL
$196B
| $2.75M | 0.01% |
45,575
+19,537
| +75% | +$1.17M |
|
661
Steris
STE
$23.1B
| $2.75M | 0.01% |
13,444
+4,049
| +43% | +$866K |
|
662
Teledyne Technologies
TDY
$32B
| $2.74M | 0.01% |
6,384
+1,976
| +45% | +$873K |
|
663
Teck Resources
TECK
$32.6B
| $2.73M | 0.01% |
109,834
+61,239
| +126% | +$1.4M |
|
|
PACW
664
DELISTED
PacWest Bancorp
PACW
| $2.72M | 0.01% |
60,091
+9,848
| +20% | +$408K |
|
665
Wheaton Precious Metals
WPM
$60.9B
| $2.72M | 0.01% |
72,392
+8,202
| +13% | +$358K |
|
|
SDC
666
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $2.7M | 0.01% |
507,757
-1,841
| -0.4% | -$11.4K |
|
667
Humana
HUM
$46.2B
| $2.7M | 0.01% |
6,933
+46
| +0.7% | +$19.5K |
|
668
XPeng
XPEV
$11.6B
| $2.7M | 0.01% |
75,873
+48,115
| +173% | +$1.91M |
|
669
IDEX
IEX
$17.3B
| $2.69M | 0.01% |
12,998
+4,927
| +61% | +$1.09M |
|
670
iShares Core Dividend Growth ETF
DGRO
$43.5B
| $2.67M | 0.01% |
53,078
+2,089
| +4% | +$108K |
|
671
Rayonier
RYN
$6.55B
| $2.65M | 0.01% |
81,840
+51,153
| +167% | +$1.71M |
|
|
CERN
672
DELISTED
Cerner Corp
CERN
| $2.64M | 0.01% |
37,388
-12,701
| -25% | -$981K |
|
|
PCH
673
DELISTED
PotlatchDeltic
PCH
| $2.63M | 0.01% |
50,927
+46,115
| +958% | +$2.41M |
|
|
ETX
674
Eaton Vance Municipal Income 2028 Term Trust
ETX
$199M
| $2.62M | 0.01% |
117,493
+24,642
| +27% | +$562K |
|
|
FISV
675
Fiserv Inc
FISV
$27.9B
| $2.62M | 0.01% |
24,153
-555
| -2% | -$62K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.